相关实验视频

Updated: May 26, 2025

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic

Published on: September 4, 2012

MiR-214通过向TRAF1来抑制NF-κB通路的激活,以缓解脂多糖诱导的乳腺炎

Yujin Gao¹, Cheng Li², Xijun Zhang¹

¹Gansu Key Laboratory of Animal Generational Physiology and Reproductive Regulation, Lanzhou, 730070, China.

|February 21, 2025

概括

在乳腺炎模型中降低的microRNAmiR-214,可以通过通过TRAF1下调抑制NF-κB通路来治疗奶牛炎症. 这为乳腺炎提供了潜在的新疗法.

科学领域:

兽医科学兽医科学兽医科学
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

乳腺炎是一种乳腺组织炎症,对乳制品行业构成重大挑战.
微RNAmiR-214是已知的炎症疾病调节剂,但其在乳腺炎中的作用尚不清楚.

研究的目的:

调查miR-214在乳牛乳腺炎中的作用.
探索miR-214在乳腺炎治疗中的治疗潜力.

主要方法:

使用了体内由脂聚糖 (LPS) 诱导的小鼠乳腺炎和体内由LPS诱导的牛乳腺上皮细胞 (bMEC) 模型.
评估了miR-214表达,炎症性细胞因子水平 (IL-1β,TNF-α,IL-6) 和核因子-κB (NF-κB) 通路的激活.
雇佣的双 luciferase 报告员测试以确定 miR-214 目标,特别是瘤死因子受体相关因子 1 (TRAF1).

主要成果:

在LPS诱导的乳腺炎模型中,miR-214表达减少.
miR-214模仿抑制的炎症性细胞因子表达和NF-κB通路激活.
miR-214直接准了TRAF1,抑制了它的表达.
沉默TRAF1模仿了miR-214的抗炎作用,而TRAF1的过度表达则逆转了它们.
在体内,miR-214减轻了乳腺组织损伤和减少了炎症.

结论:

miR-214通过TRAF1下调抑制NF-κB激活来缓解乳腺炎中LPS诱导的炎症反应.
miR-214提出了一种潜在的新疗法策略,用于治疗奶牛乳腺炎.

关键词:

乳牛乳腺炎是一种乳牛乳腺炎.在 NF-κBB 中.在TRAF1上.在 miR-21414 中.

更多相关视频

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Inflammation

Inflammation

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...